New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ObsEva SA
OBSV
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

11M

Biotechnology

0.10USD

0.00 ( 0.00%)
sun-fogPre-market 0.00$arrow-left-down-0.10 (-100.00%)
Market Closed (as of Mar 22, 20:00 EDT)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

4%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

95%

Quote Panel

Shape
Updated February 5, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    11.00M


  • Shares Outstanding

    108.02M


  • Share in Float

    93.52M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.1018


  • Average Volume

    7.95M


  • Beta

    0.6745


  • Range

    0.065-2.14


  • Industry

    Biotechnology


  • Website

    https://www.obseva.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.56x

P/S Ratio

1.11x

P/B Ratio

0.4

Debt/Equity

-152.2%

Net Margin

$-0.7

EPS

How OBSV compares to sector?

P/E Ratio

Relative Strength

Shape

OBSV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

H.C. Wainwright

downgrade

Previous: Not converted

2022-08-30

Now: Buy

Cantor Fitzgerald

initialise

Previous: Not converted

2022-06-03

Now: Overweight

Zacks Investment Research

downgrade

Previous: Not converted

2022-04-26

Now: Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.20

arrow
arrow

N/A

-0.49
vs -0.63

Q4.20

arrow
arrow

N/A

-0.32
vs -0.48

Q1.21

arrow
arrow

N/A

-0.29
vs -0.48

Q2.21

arrow
arrow

N/A

-0.25
vs -0.38

Q3.21

arrow
arrow

+102%

0.01
vs -0.49

Q4.21

arrow
arrow

N/A

-0.26
vs -0.32

Q1.22

arrow
arrow

N/A

-0.14
vs -0.29

Q2.22

arrow
arrow

N/A

-0.39
vs -0.25

Q3.22

arrow
arrow

N/A

-0.13
vs 0.01

Q4.22

arrow
arrow

N/A

-0.26
vs -0.26

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.20

arrow
arrow

NA

NA  vs NA

Q4.20

arrow
arrow

NA

NA  vs NA

Q1.21

arrow
arrow

NA

NA  vs NA

Q2.21

arrow
arrow

NA

NA  vs NA

Q3.21

arrow
arrow

NA

NA  vs NA

Q4.21

arrow
arrow

NA

NA  vs NA

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

19.6M  vs NA

Return on EquityShape

status-upQoQ

Q1.21

arrow
arrow

-40%

-0.40
vs -2.22

Q2.21

arrow
arrow

-46%

-0.46
vs -0.40

Q3.21

arrow
arrow

+2%

0.02
vs -0.46

Q4.21

arrow
arrow

-62%

-0.62
vs 0.02

Q1.22

arrow
arrow

-42%

-0.42
vs -0.62

Q2.22

arrow
arrow

+1560%

15.6
vs -0.42

Q3.22

arrow
arrow

+383%

3.83
vs 15.6

Q4.22

arrow
arrow

+316%

3.16
vs 3.83

Institutionnal OwnershipShape

status-upQoQ

Q2.21

arrow
arrow

44

44
vs 53

-17%

Q3.21

arrow
arrow

43

43
vs 44

-2%

Q4.21

arrow
arrow

44

44
vs 43

2%

Q1.22

arrow
arrow

42

42
vs 44

-5%

Q2.22

arrow
arrow

37

37
vs 42

-12%

Q3.22

arrow
arrow

27

27
vs 37

-27%

Q4.22

arrow
arrow

27

27
vs 27

NA

Q1.23

arrow
arrow

4

4
vs 27

-85%

Earnings Growth

Latest News

OBSV

globenewswire.com

17 hours ago